Menopause App: The menopause app facilitates the implementation of multimodal self-management strategies in the daily routines of individuals with a menopausal disorder, through tools such as a symptom diary and guided interactive exercises.
Study summary
This study examines whether a digital app can help women manage symptoms of menopause. A total of 426 women with medically confirmed menopausal symptoms are randomly assigned to either use the app in addition to their usual medical care for 24 weeks, or to continue with usual care alone. The app provides evidence-based content and exercises for multimodal menopause management. Participants are followed up over 24 weeks, with the primary outcome assessed at 12 weeks. The main goal is to evaluate whether the app improves menopause-specific quality of life.
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Legal capacity
* Ability to provide informed consent
* Residency in Germany
* Female gender
* Age ≥18 years
* Medically confirmed menopausal or other perimenopausal disorder (N95.1)
* Ownership of a smartphone and ability to use it
* Internet access for app usage and questionnaire completion
* Email address for registration
* Willingness to complete questionnaires online
* Motivation for regular app usage
* Sufficient proficiency in the German language
* MRS II ≥ 9
* Absence of exclusion criteria
Exclusion Criteria:
* Pregnancy or breastfeeding during the study period
* Current hormonal replacement therapy (HRT), initiation of HRT within eight weeks prior to study start and/or planned start of HRT during the study period
* Changes in treatment with psychotropic medication within eight weeks prior to study start and/or planned during the study period
* Start of psychotherapy within eight weeks prior to study start and/or planned during the study period
* Start of a rehabilitation program within eight weeks prior to study start and/or planned during the study period
* Surgery performed within eight weeks prior to study start and/or planned during the study period
* Previous or current access to the Endo-App or other comparable digital health applications, or current active prescription
* Current participation in other clinical studies
* Failure to meet the inclusion criteria
Primary outcome measure(s)
Menopause-specific quality of life — Changes between time point T0 (baseline) and T3 (12 weeks after baseline) Assessed with the Menopause-specific Quality of Life Questionnaire (MENQOL)
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.